| Michael L Kuczmanski, MD | |
|
300 Tower Rd Ne, Ste 200, Marietta, GA 30060-9403 | |
| (770) 427-5717 | |
| (770) 429-6503 |
| Full Name | Michael L Kuczmanski |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 28 Years |
| Location | 300 Tower Rd Ne, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457354151 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 051594 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Northside Hospital Cherokee | Canton, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Orthopaedics And Sports Medicine Specialists Llc | 6204723216 | 42 |
News Archive
A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of "low value" by the U.S. Preventive Services Task Force -; at a cost of $478 million per year.
Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online today (Thursday 11 March) in the European Heart Journal.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
Diabetic kidney diseases are the main cause of kidney failure in industrialized countries. An international, EU-funded R&D project - which is being headed by the Medical University of Innsbruck, and involves collaboration with the Medical University of Vienna and international partners - is being implemented with the aim of using computer software to provide personalized predictions of the disease's progression and bring about improvements in individuals' responses to treatment.
› Verified 3 days ago
| Entity Name | Pinnacle Orthopaedics & Sports Medicine Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194815175 PECOS PAC ID: 6204723216 Enrollment ID: O20040303001053 |
News Archive
A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of "low value" by the U.S. Preventive Services Task Force -; at a cost of $478 million per year.
Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online today (Thursday 11 March) in the European Heart Journal.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
Diabetic kidney diseases are the main cause of kidney failure in industrialized countries. An international, EU-funded R&D project - which is being headed by the Medical University of Innsbruck, and involves collaboration with the Medical University of Vienna and international partners - is being implemented with the aim of using computer software to provide personalized predictions of the disease's progression and bring about improvements in individuals' responses to treatment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael L Kuczmanski, MD 300 Tower Rd Ne, Ste 200, Marietta, GA 30060-9403 Ph: (770) 427-5717 | Michael L Kuczmanski, MD 300 Tower Rd Ne, Ste 200, Marietta, GA 30060-9403 Ph: (770) 427-5717 |
News Archive
A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of "low value" by the U.S. Preventive Services Task Force -; at a cost of $478 million per year.
Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online today (Thursday 11 March) in the European Heart Journal.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
Diabetic kidney diseases are the main cause of kidney failure in industrialized countries. An international, EU-funded R&D project - which is being headed by the Medical University of Innsbruck, and involves collaboration with the Medical University of Vienna and international partners - is being implemented with the aim of using computer software to provide personalized predictions of the disease's progression and bring about improvements in individuals' responses to treatment.
› Verified 3 days ago
Dr. Jeffrey Alan Wener, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2520 Windy Hill Rd Se, Suite 202, Marietta, GA 30067 Phone: 770-953-0900 Fax: 770-952-0492 | |
Dr. John M Pinski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 61 Whitcher St Ne Ste 1100, Marietta, GA 30060 Phone: 770-422-3290 Fax: 770-422-0287 | |
Dr. Ethan Wesley Dean, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 620 Cherokee St Ne Ste 300, Marietta, GA 30060 Phone: 770-635-1812 Fax: 770-485-2883 | |
David Lee Smith Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Whitcher St Ne Ste 130, Marietta, GA 30060 Phone: 770-428-0462 Fax: 770-427-8001 | |
Dr. Joe Leonard Hughes, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4981 Lake Fjord Pass, Marietta, GA 30068 Phone: 770-992-1589 | |
Dr. Richard W Cohen, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 61 Whitcher St Ne, Suite 1100, Marietta, GA 30060 Phone: 770-422-3290 Fax: 770-422-0287 | |
Clarence Lyn Crooms, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3823 Roswell Rd, Suite 202, Marietta, GA 30062 Phone: 770-579-8558 Fax: 770-973-1934 |